P

Pfizer

Pfizer saves 16,000 scientist hours annually and cuts infrastructure costs 55% with AWS generative AI for drug development

Curated & reviewed by Peter Korpak, Founder & Chief Analyst, 100SignalsHow we verify
16,000 hoursScientist Search Time Saved Annually
55%Infrastructure Cost Reduction
Up to 80%Data Discovery Time Reduction (Target)

Vendor-reported figures — source: aws.amazon.com

Pfizer
Metric Before After Impact
Scientist Search Time Saved Annually 16,000 hours 16,000 hours saved annually
Infrastructure Costs 100% 45% 55% reduction
Data Discovery Time up to 80% reduction up to 80% faster discovery

The Challenge

Pfizer's 1,500 pharmaceutical scientists spent excessive time on manual data discovery across fragmented repositories. The development of a single drug can generate approximately 20,000 documents, making it difficult to find historical data efficiently. The company also lacked internal bandwidth for rapid prototyping of new AI/ML solutions.

The Solution

Through the Pfizer-Amazon Collaboration Team (PACT) initiative, Pfizer deployed Amazon Bedrock with Anthropic's Claude 2.1 for natural language search via voice command and chatbot on an internal platform called Vox. Amazon Kendra was developed to enable intelligent enterprise search across content repositories. A separate PCMM anomaly detection system was built using Amazon SageMaker, Amazon Lookout for Equipment, and Amazon Lookout for Metrics to monitor continuous pharmaceutical manufacturing.

Results

Scientists can now save up to 16,000 hours of searching and extracting data annually. Infrastructure costs were reduced by 55%. Five of the 14 PACT prototypes have moved into production, and the initiative has spread innovation culture across multiple Pfizer groups and business lines.

Key Takeaways

  • Rapid 6-week prototyping cycles (vs. 3+ months internally) enabled by a dedicated vendor collaboration team accelerate innovation without consuming internal engineering bandwidth.
  • Generative AI applied to document-heavy scientific workflows can yield significant time savings at scale — 16,000 hours across 1,500 scientists.
  • A structured "fail fast" prototype-to-MVP pipeline is effective for de-risking AI investments in regulated life sciences environments.

Share:

Details

Company Size
Enterprise
Company
Pfizer
Quality
Curated
Last verified
Jul 28, 2026

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →